Security key
68403P203
ORAMED PHARMACEUTICALS INC. - Common Stock (ORMP)
CUSIP: 68403P203
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 1,235,726
- Total 13F value
- $64,175,840
- Share change
- -222,824
- Put/Call ratio
- 31%
- SEC-reported price per share
- $10.16
- Number of holders
- 43
- Value change
- +$52,410,474
- Number of buys
- 28
- Number of sells
- 11
- Shares outstanding
- 40,467,431
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2021
Institutions
43
Top holders
10
ORMP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2021
Previous quarter: Q4 2020
ORAMED PHARMACEUTICALS INC. SEC filings
ORAMED PHARMACEUTICALS INC. company facts
ORAMED PHARMACEUTICALS INC. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 68403P203
Recent filing periods:
Ownership snapshot
Top reported holders of ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MORGAN JESS S & CO INC
Disclosed value leader
MORGAN JESS S & CO INC
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F
Lead comparable stake: 1.4%
Showing 1-6 of 15 holder rows.
Quick read
MORGAN JESS S & CO INC leads the comparable SEC ownership view at 1.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MORGAN JESS S & CO INC's linked filing trail.
Comparable ownership
Top 5
MORGAN JESS S & CO INC
1.4%
RENAISSANCE TECHNOLOGIES LLC
0.92%
Frontier Wealth Management LLC
0.18%
BlackRock Finance, Inc.
0.17%
Qube Research & Technologies Ltd
0.13%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN JESS S & CO INC |
13F
Company
|
1.4%
|
$2,448,000
577,317 shares
|
— | 31 Dec 2020 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.92%
|
$1,579,000
372,415 shares
|
— | 31 Dec 2020 |
| Frontier Wealth Management LLC |
13F
Company
|
0.18%
|
$305,000
71,900 shares
|
— | 31 Dec 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
0.17%
|
$292,000
68,735 shares
|
— | 31 Dec 2020 |
| Qube Research & Technologies Ltd |
13F
Company
|
0.13%
|
$230,000
54,291 shares
|
— | 31 Dec 2020 |
| MARSHALL WACE, LLP |
13F
Company
|
0.09%
|
$155,000
36,632 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
43
Shares
1,235,726
Rows available
43
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
36
Q1 2021 holders
43
Holder diff
7
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend